MUC1 and breast carcinoma: Carcinoma-associated MUC1 is known to be recognized by the immune system in cancer patients [10], [11], [12], and MUC1-specific cytotoxic T lymphocytes (CTLs) have been detected in colon, pancreatic, and breast carcinoma patients [13], [14].